On June 13, Tarcine Biotechnic Diagnostics sponsored Macau Institute of Medical Laboratory Service to hold a seminar “ST2 Application on Prognosis and Treatment of Heart Failure” at Macau Kiang Wu Hospital. Dr. Yao Kang from Zhongshan Hospital Fudan University shared his clinical experience and stated precisely the benefits of ST2 on diagnosis and treatment of heart failure. All attendees had the positive evaluation on ST2 and expected it could help on saving the lives of heart failure patients more effectively.
Tarcine Biotechnic Diagnostics Limited is the sole distributor of Critical Diagnostics Inc. in Hong Kong and Macau. Having proven by many clinical studies, ST2 is indicated to be used in conjunction with clinical evaluation as an aid in for assessing the prognosis of patients diagnosed with heart failure and was included in the 2013 ACC/AHA Guideline for Heart Failure Management. Presage ST2 Assay has FDA Cleared and CE Marked already.